9002 A phase III, first-line trial of gefitinib versus cisplatin plusdocetaxel for patients with advanced or recurrent non-small cell lungcancer (NSCLC) harboring activating mutation of the epidermal growthfactor receptor (EGFR) gene: a preliminary ...

Details

Language :

English

ISSN :

13596349

Volume :

7

Issue :

2

Database :

Supplemental Index

Journal :

EJC Supplements

Publication Type :

Academic Journal

Accession number :

44463815

Full Text :

https://doi.org/10.1016/S1359-6349(09)71715-X